Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 15.41 and Closed at: 14.22, which is -8.65% of previous session's close. It moved within a range of 14.10 and 15.60
The session was a Bearish session with an average volume of 4558582, which is -44.31% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
Support for tomorrow is 13.41 and resistance for tomorrow is 14.91
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 13.68, 13.14 resistance for tomorrow's hourly charts is 15.18, 16.14
10 Day SMA for Intellia Therapeutics (NTLA) is 16.68 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 15.71 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 14.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 13.94 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 13.7 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 15.71 and 200 DMA is at 13.7, while 50 DMA and 100 DMA are at 14.31 and 13.94 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 15.71 and 20 EMA is at 15.72
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 14.22 | 15.71 | 15.72 |
| 09 Thu Jul | 15.45 | 15.61 | 15.88 |
| 08 Wed Jul | 16.84 | 15.48 | 15.93 |
| 07 Tue Jul | 17.42 | 15.31 | 15.83 |
| 06 Mon Jul | 17.87 | 15.12 | 15.66 |
| 02 Thu Jul | 17.56 | 14.96 | 15.43 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 14.31 and 50 EMA is at 14.77
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 14.22 | 14.31 | 14.77 |
| 09 Thu Jul | 15.45 | 14.27 | 14.79 |
| 08 Wed Jul | 16.84 | 14.23 | 14.76 |
| 07 Tue Jul | 17.42 | 14.15 | 14.67 |
| 06 Mon Jul | 17.87 | 14.08 | 14.56 |
| 02 Thu Jul | 17.56 | 14.04 | 14.43 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.94 and 100 EMA is at 14.08
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 14.22 | 13.94 | 14.08 |
| 09 Thu Jul | 15.45 | 13.92 | 14.08 |
| 08 Wed Jul | 16.84 | 13.88 | 14.05 |
| 07 Tue Jul | 17.42 | 13.83 | 13.99 |
| 06 Mon Jul | 17.87 | 13.78 | 13.92 |
| 02 Thu Jul | 17.56 | 13.72 | 13.84 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 13.7 and 200 EMA is at 13.28
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 14.22 | 13.7 | 13.28 |
| 09 Thu Jul | 15.45 | 13.71 | 13.27 |
| 08 Wed Jul | 16.84 | 13.72 | 13.25 |
| 07 Tue Jul | 17.42 | 13.72 | 13.21 |
| 06 Mon Jul | 17.87 | 13.71 | 13.17 |
| 02 Thu Jul | 17.56 | 13.68 | 13.12 |
Zai Lab has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Zai Lab, about 1.11% more returns!
Intellia Therapeutics has performed better than Vistagen Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Verrica Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Rigel Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 17.52% more returns!
Intellia Therapeutics has performed better than Ovid Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Myriad Genetics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Myriad Genetics, about 11.08% more returns!
Intellia Therapeutics has performed better than Liquidia Technologies in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Assembly Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 6.65% more returns!
Intellia Therapeutics has performed better than Biolife Solutions in short term. Holding Intellia Therapeutics could be a better choice for now!
Corvus Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 19.92% more returns!
Intellia Therapeutics has performed better than Electrocore Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Enanta Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 3.89% more returns!
Intellia Therapeutics has performed better than Grifols S in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Halozyme Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Harrow Health in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Incyte Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Ionis Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term but the sell signal is initial and weak.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.44 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
